qwerty
Well-known member
http://www.cnbc.com/id/101599582
looks like a lot of corporate folks will be losing their jobs if this materializes
looks like a lot of corporate folks will be losing their jobs if this materializes
irvinehomehater said:I was involved with some of the talks... This is gonna piss off a lot of people.
Yeah, they are definitely gonna cut the fat over there. Hope the people that get cut have some stock options.qwerty said:irvinehomehater said:I was involved with some of the talks... This is gonna piss off a lot of people.
so you think it will happen? from looking at valeants history, this doesnt look good for the finance and R&D teams.
Actavis announced on Monday that it will acquire Allergan for $66 billion, or $219 per share in cash and Actavis shares.
The deal beats the unsolicited bid last spring of above $50 billion from Valeant, which teamed with Bill Ackman's hedge fund Pershing Square Capital Management.
irvinehomeowner said:Is Actavis a better buyer?
From what someone told me, they were afraid of the Valeant deal because when Valeant acquires companies they don't continue to invest in development and research.